跳至主要内容
临床试验/EUCTR2016-001900-47-NL
EUCTR2016-001900-47-NL进行中(未招募)1 期

The effect of lidocaine infusion on ad libitum food intake and satiety in healthy volunteers - Lidocaine infusion and food intake

Maastricht University Medical Centre +0 个研究点目标入组 35 人开始时间: 2017年4月13日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Male

入选标准

  • Based on medical history and previous examination, no
  • gastrointestinal complaints can be defined.
  • Age between 18 and 50 years. Several studies (see introduction)
  • showed a difference in response to a meal between young and elderly
  • people. Inclusion of elderly could interfere with the outcome of this
  • study. Goal of this study is to investigate whether a difference in food
  • intake can be found after intragastric infusion of a local anaesthetic. For
  • this proof of concept study we therefore choose to include healthy male
  • volunteers with a maximum age of 50 years. This study will include
  • healthy male subjects.
  • BMI between 20 and 25 kg/m2)
  • Weight stable over at least the last 6 months (=5% weight change)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 35
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Females, because of their hormonal cycle and the possible influence
  • of these hormones on eating behaviour.
  • History of severe cardiovascular, respiratory, urogenital,
  • gastrointestinal/hepatic, haematological/immunologic, HEENT (head,
  • ears, eyes, nose, throat), dermatological/connective tissue,
  • musculoskeletal, metabolic/nutritional, endocrine,
  • neurological/psychiatric diseases, allergy, major surgery and/or
  • laboratory assessments which might limit participation in or completion
  • of the study protocol. The severity of the disease (major interference
  • with the execution of the experiment or potential influence on the study
  • outcomes) will be decided by the principal investigator.
  • Use of amiodaron, because of the cardiotoxicity (in combination with
  • lidocaine).
  • Use of beta blockers, cimetidine and norepinephrine (synergetic
  • effect on the action of Lidocaine).
  • Other use of medication, which could interfere with the outcome of
  • the study. This will be decided by the principal investigator.
  • Administration of investigational drugs or participation in any
  • scientific intervention study which may interfere with this study (to be
  • decided by the principle investigator), in the 90 days prior to the study
  • Major abdominal surgery interfering with gastrointestinal function
  • (uncomplicated appendectomy, cholecystectomy and hysterectomy
  • allowed, and other surgery upon judgement of the principle investigator)
  • Dieting (medically prescribed, vegetarian, diabetic, macrobiological,
  • biological dynamic)
  • Excessive alcohol consumption (>20 alcoholic consumptions per
  • Self-admitted HIV-positive state
  • Any food allergy
  • Not able to eat a chili con carne meal.

研究者

发起方
Maastricht University Medical Centre +

相似试验